OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling
Claudia Fuchs, Giorgio Medici, Stefania Trazzi, et al.
Brain Pathology (2019) Vol. 29, Iss. 5, pp. 658-674
Open Access | Times Cited: 24

Showing 24 citing articles:

Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy
Priscilla D. Negraes, Cleber A. Trujillo, Nam‐Kyung Yu, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 7047-7068
Open Access | Times Cited: 54

CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development
Nicole J. Van Bergen, Sean Massey, Anita Quigley, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 4, pp. 1207-1224
Open Access | Times Cited: 31

Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder
Giuseppe Galvani, Nicola Mottolese, Laura Gennaccaro, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 33

Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder
Marianna Tassinari, Nicola Mottolese, Giuseppe Galvani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8719-8719
Open Access | Times Cited: 24

Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic
Shilpa D. Kadam, Brennan J. Sullivan, Archita Goyal, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 5098-5098
Open Access | Times Cited: 41

Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder
Syouichi Katayama, Noriyuki Sueyoshi, T. INAZU, et al.
Neural Plasticity (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 35

Unveiling Molecular Dynamics of MeCp2, CDKL5 and BDNF in the Hippocampus of Individuals With Intractable Mesial Temporal Lobe Epilepsy
NoorMohammad Meshkinkhood, Parastoo Barati Dowom, Farshid Noorbakhsh, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 3
Open Access

The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
Luca Trovò, Claudia Fuchs, Roberta De Rosa, et al.
Neurobiology of Disease (2020) Vol. 138, pp. 104791-104791
Open Access | Times Cited: 32

Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and Death
Laura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Aging and Disease (2021) Vol. 12, Iss. 3, pp. 764-764
Open Access | Times Cited: 25

Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?
Isabella Barbiero, Roberta De Rosa, Charlotte Kilstrup‐Nielsen
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4075-4075
Open Access | Times Cited: 23

Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons
Manuela Loi, Stefania Trazzi, Claudia Fuchs, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 5, pp. 2244-2262
Closed Access | Times Cited: 23

Stress-Sensitive Protein Rac1 and Its Involvement in Neurodevelopmental Disorders
Xiaohui Wang, Dongbin Liu, Fangzhen Wei, et al.
Neural Plasticity (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 23

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder
Manuela Loi, Laura Gennaccaro, Claudia Fuchs, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5950-5950
Open Access | Times Cited: 18

A review of CDKL: An underestimated protein kinase family
Chenrui Li, Yan Liu, Shilu Luo, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 133604-133604
Open Access | Times Cited: 2

Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder
Claudia Fuchs, Laura Gennaccaro, Elisa Ren, et al.
Neuropharmacology (2019) Vol. 167, pp. 107746-107746
Closed Access | Times Cited: 17

Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder
Nicola Mottolese, Beatrice Uguagliati, Marianna Tassinari, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1396-1396
Open Access | Times Cited: 5

Research progress on the pathogenesis of CDKL5 pathogenic variants and related encephalopathy
Xuyan Sun, Tiancheng Wang
European Journal of Pediatrics (2023) Vol. 182, Iss. 7, pp. 3049-3056
Closed Access | Times Cited: 3

Novel CDKL5 targets identified in human iPSC-derived neurons
Sean Massey, Ching‐Seng Ang, N. Davidson, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access

Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder
Nicola Mottolese, Manuela Loi, Stefania Trazzi, et al.
Journal of Neurodevelopmental Disorders (2024) Vol. 16, Iss. 1
Open Access

Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder
Nicola Mottolese, Beatrice Uguagliati, Marianna Tassinari, et al.
(2023)
Open Access | Times Cited: 1

Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder
Nicola Mottolese, Beatrice Uguagliati, Marianna Tassinari, et al.
(2023)
Open Access | Times Cited: 1

Corrigendum

Brain Pathology (2020) Vol. 30, Iss. 3, pp. 721-721
Open Access

Page 1

Scroll to top